Key facts
- Pfizer has partnered with Chai Discovery.
- The pact involves using Chai Discovery's AI platform for drug development.
- The goal is to accelerate the discovery and creation of new medicines.
Pfizer has announced a collaboration with Chai Discovery, a company specializing in artificial intelligence for drug development. The agreement will see Pfizer utilize Chai Discovery's AI platform with the objective of speeding up the process of discovering and creating new pharmaceutical treatments. This partnership signifies a move towards integrating advanced AI technologies into the core functions of drug research and development within the pharmaceutical industry.